Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully explore